Broad adoption of vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is key to successfully fighting the spread of coronavirus disease 2019 (COVID-19). When fallen ill with COVID-19, in-center hemodialysis patients are at particularly high risk for morbidity and mortality.1 , 2 Therefore, attaining high vaccination rates in both dialysis patients and staff is of utmost importance.

The New York State Department of Health COVID-19 vaccination plan calls for a phased distribution of the vaccine (https://covid19vaccine.health.ny.gov/phased-distribution-vaccine). In accordance with that plan, all outpatient/ambulatory front-line, high-risk health care workers of any age who provide direct in-person patient care are eligible for vaccination; this definition includes dialysis staff.

Here we report dialysis staff vaccination acceptance and hesitancy rates from 4 Renal Research Institute dialysis clinics and a home dialysis program located in New York, New York. Inoculation of the first dose was done between 13 and 21 January 2021. The staff count was 157, including full-time and part-time employees, temporary workers, and per diem staff. Staff who were pregnant or breast feeding, were on leave of absence, had contracted COVID-19 less than 90 days ago, or explicitly expressed vaccination hesitancy were not offered inoculation. Staff with a history of confirmed COVID-19 more than 90 days ago or at some unknown time in the past were offered vaccination; while in principle willing to get inoculated, these staff members wished to receive the vaccine later. Six employees (3.8%) explicitly expressed vaccination hesitancy